Pine Valley Investments’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$759K Buy
3,992
+40
+1% +$6.88K 0.03% 340
2026
Q1
$667K Sell
3,952
-31
-0.8% -$5.3K 0.03% 341
2025
Q4
$672K Sell
3,983
-33
-0.8% -$5.36K 0.03% 323
2025
Q3
$580K Sell
4,016
-64
-2% -$8.74K 0.03% 335
2025
Q2
$516K Sell
4,080
-119
-3% -$14.6K 0.03% 339
2025
Q1
$537K Sell
4,199
-53
-1% -$7.19K 0.03% 329
2024
Q4
$562K Sell
4,252
-704
-14% -$99K 0.03% 320
2024
Q3
$722K Sell
4,956
-1,745
-26% -$252K 0.04% 272
2024
Q2
$920K Sell
6,701
-153
-2% -$20.4K 0.06% 239
2024
Q1
$941K Sell
6,854
-68
-1% -$9.29K 0.06% 236
2023
Q4
$940K Sell
6,922
-1,148
-14% -$140K 0.07% 224
2023
Q3
$987K Buy
8,070
+2,460
+44% +$313K 0.09% 211
2023
Q2
$712K Buy
5,610
+1,831
+48% +$238K 0.07% 225
2023
Q1
$494K Buy
+3,779
New +$495K 0.07% 182

Other funds holding IBB

Pine Valley Investments's IBB Position: Q2 2026 in Review

Pine Valley Investments increased its iShares Biotechnology ETF (IBB) stake by 1% in Q2 2026, buying an estimated $6.88K and bringing the position to 3,992 shares worth $759K. The position accounts for 0.03% of the portfolio, ranked #340.

Pine Valley Investments first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. The position peaked at $987K in Q3 2023. 550 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Pine Valley Investments held 3,992 shares of iShares Biotechnology ETF worth $759K as of Q2 2026.
  • Pine Valley Investments bought 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
  • iShares Biotechnology ETF made up 0.03% of Pine Valley Investments's portfolio in Q2 2026, its #340 holding.
  • Pine Valley Investments first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
  • Pine Valley Investments's iShares Biotechnology ETF position peaked at $987K in Q3 2023.
  • 550 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.